JPS5350316A - Drug composition for oral administration - Google Patents

Drug composition for oral administration

Info

Publication number
JPS5350316A
JPS5350316A JP12351476A JP12351476A JPS5350316A JP S5350316 A JPS5350316 A JP S5350316A JP 12351476 A JP12351476 A JP 12351476A JP 12351476 A JP12351476 A JP 12351476A JP S5350316 A JPS5350316 A JP S5350316A
Authority
JP
Japan
Prior art keywords
drug composition
oral administration
fatty acid
acid salt
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12351476A
Other languages
Japanese (ja)
Other versions
JPS5940137B2 (en
Inventor
Hitoshi Sezaki
Shozo Muranishi
Koji Yashiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP51123514A priority Critical patent/JPS5940137B2/en
Publication of JPS5350316A publication Critical patent/JPS5350316A/en
Publication of JPS5940137B2 publication Critical patent/JPS5940137B2/en
Expired legal-status Critical Current

Links

Abstract

PURPOSE: To provide a drug composition having remarkably improved absorbability, by incorporating a bile acid salt and a fatty acid monoglyceride or a higher fatty acid salt to a drug component which is difficult to be absorbed through digestive tract.
COPYRIGHT: (C)1978,JPO&Japio
JP51123514A 1976-10-14 1976-10-14 Pharmaceutical composition for oral administration Expired JPS5940137B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP51123514A JPS5940137B2 (en) 1976-10-14 1976-10-14 Pharmaceutical composition for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51123514A JPS5940137B2 (en) 1976-10-14 1976-10-14 Pharmaceutical composition for oral administration

Publications (2)

Publication Number Publication Date
JPS5350316A true JPS5350316A (en) 1978-05-08
JPS5940137B2 JPS5940137B2 (en) 1984-09-28

Family

ID=14862484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51123514A Expired JPS5940137B2 (en) 1976-10-14 1976-10-14 Pharmaceutical composition for oral administration

Country Status (1)

Country Link
JP (1) JPS5940137B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069028A (en) * 1983-05-23 1985-04-19 ハダサ・メデイカル・オ−ガニゼイシヨン Drug composition containing insulin
AT388499B (en) * 1985-08-02 1989-06-26 Merz & Co Gmbh & Co METHOD FOR PRODUCING AN ANTIVIRAL AND ANTITUMOR COMPOSITION, AND THE USE THEREOF
AT392904B (en) * 1984-03-19 1991-07-10 Bristol Myers Squibb Co METHOD FOR PRODUCING A SOFT GEL CAPSULE INTENDED FOR THE ORAL ADMINISTRATION OF ETOPOSIDE
WO1993015729A1 (en) * 1992-02-07 1993-08-19 Tsumura & Co. Side-effect alleviant
US5444041A (en) * 1991-04-19 1995-08-22 Ibah, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
JPH09511744A (en) * 1994-04-07 1997-11-25 ファーマヴィーン，インコーポレイテッド Multi-layer drug delivery system
KR100508695B1 (en) * 2001-02-13 2005-08-17 한국과학기술연구원 Formulation for oral delivery of insulin and preparation method thereof
JP2014534204A (en) * 2011-10-21 2014-12-18 ネステク ソシエテ アノニム Use of whey protein micelles to improve insulin profile in diabetic patients

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069028A (en) * 1983-05-23 1985-04-19 ハダサ・メデイカル・オ−ガニゼイシヨン Drug composition containing insulin
AT392904B (en) * 1984-03-19 1991-07-10 Bristol Myers Squibb Co METHOD FOR PRODUCING A SOFT GEL CAPSULE INTENDED FOR THE ORAL ADMINISTRATION OF ETOPOSIDE
AT388499B (en) * 1985-08-02 1989-06-26 Merz & Co Gmbh & Co METHOD FOR PRODUCING AN ANTIVIRAL AND ANTITUMOR COMPOSITION, AND THE USE THEREOF
US5444041A (en) * 1991-04-19 1995-08-22 Ibah, Inc. Convertible microemulsion formulations
US5633226A (en) * 1991-04-19 1997-05-27 Lds Technologies, Inc. Convertible microemulsion formulations
US5646109A (en) * 1991-04-19 1997-07-08 Lds Technologies, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
WO1993015729A1 (en) * 1992-02-07 1993-08-19 Tsumura & Co. Side-effect alleviant
JPH09511744A (en) * 1994-04-07 1997-11-25 ファーマヴィーン，インコーポレイテッド Multi-layer drug delivery system
KR100508695B1 (en) * 2001-02-13 2005-08-17 한국과학기술연구원 Formulation for oral delivery of insulin and preparation method thereof
JP2014534204A (en) * 2011-10-21 2014-12-18 ネステク ソシエテ アノニム Use of whey protein micelles to improve insulin profile in diabetic patients

Also Published As

Publication number Publication date
JPS5940137B2 (en) 1984-09-28

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
JPS53107408A (en) Micellar preparation for rectal infusion
IE42950L (en) X-ray contrast preparations
JPS5350316A (en) Drug composition for oral administration
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
NZ184722A (en) Pharmaceutical compositions with controlled release of active agent in the intestinal tract
NZ195058A (en) 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions
JPS55122715A (en) Antidiabetic agent
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS52130905A (en) Medicinal composition
JPS5315429A (en) Remedies for digestive canal ulcer
JPS5498339A (en) Carcinostatic agent
JPS536414A (en) Carboxylic acid aluminum salts and their preparation
JPS5420127A (en) Solid nifedipine preparaton
JPS5473128A (en) Blood lipid depressing agent
JPS52102280A (en) 5,7,8-trimethyltocotrienol-nicotinic acid esters and preparation there of
JPS5223058A (en) Preparation of indanylpropionic acid derivatives
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS5350319A (en) Drug discharging means of medical capsule
JPS5566509A (en) Carcinostatic
JPS54135231A (en) Cardio-vasocular medicine
JPS53148536A (en) Carcinostatic agent containing trans-4-aminomethylcyclohexane-1-carboxylic acid derivative
JPS5283473A (en) Preparation of 2-styryl-3, 1-benzoxazine-4-one derivatives
JPS5426326A (en) Poultice